Advancing Vision with Retinal Dystrophy Treatment at Eyestemcellcenter
August 02, 2024/ 0 comment
Advancing Vision with Retinal Dystrophy Treatment at Eyestemcellcenter
Retinal dystrophies form a large group of hereditary diseases which manifest the gradual destruction of the photoreceptive part of the eye and, in most cases, lead to blindness. These are conditions that remain a challenge to patients and clinicians due to their features such as retinitis pigmentosa as well as Stargardt diseases. But medical advancements especially the recently discovered stem cell therapy is a breakthrough In Retinal Dystrophy Treatment.
Understanding Retinal Dystrophy
Retinal dystrophies are a group of genetically caused diseases that primarily affect the photoreceptor retinae or the layers of cells located at the back of the eye. These conditions usually result from genes that code for the function and survival of retinal cells comprising of rods and cones and other auxiliary cells such as the RPE. Due to the continuous degeneration of these cells, poor vision is experienced depending on the extent, ranging from mere night blindness to total blindness.
Stem Cell Therapy is a Breakthrough Strategy
The application of stem cells is considered as one of the perspectives in the Retinal Dystrophy Treatment since stem cells can restore or replace the lost retinal cells and protect the residual vision. This novel strategy utilises the health-generating capability of stem cells, retinal progenitor cells, iPSCs and other stem cells that help in vision recovery and put a lid on the advancement of eye diseases.
The types of stem cells used
In the context of treating retinal dystrophies, different types of stem cells are utilized:
Retinal Progenitor Cells: These cells develop into different categories of retinal cells. These are like photoreceptors and the RPE cells.
Induced Pluripotent Stem Cells (iPSCs): Is an adult cell. This in turn can be guided to form retinal cells. They lay the foundation for the patient’s genetic structure.
Mechanisms of Action
Stem cell therapy for retinal dystrophies operates through several key mechanisms:
Cell Replacement: Stem cells are grafted onto the damaged area of the retina and these cells then replace all the damaged or lost cells in the retina as well as other tissues.
Neuroprotective Effects: Stem cells also produce neurotrophic factors that maintain the growth of the already existing retinal cells thereby preventing them from degenerating.
Anti-inflammatory Properties: Stem cells have a way of regulating the immune response in that region hence reducing inflammation and this promotes survival of cells in that region and regeneration.
Retinal Dystrophy Treatment at Eyestemcellcenter
Eyestem Cell Center is an expert in applying stem cell therapy in the treatment of retinal dystrophies. Our approach is characterized by:
Comprehensive Evaluation to identify the disease status and distinguish the further course and specific management strategy for patients.
Advanced Treatment Techniques which include the establishment of modern operating theatres coupled with skilled operations in the administration of stem cell treatment services.
Research and Development which involves engagement and participation in clinical practises and research to enhance stem cell therapies for the treatment of retinal dystrophies and contribute to the fight against the diseases.
At Eyestemcellcenter utmost care is taken to maintain the guidelines provided by governing bodies like the FDA or equivalent authority. The welfare of the patient is always on top of our list and our processes include proper screening, checking on the patient, and a follow-up of how the particular treatment is working for the patient.
The results of stem cell therapy for patients with RDs are rather encouraging, as the majority of the patients reported visual acuity enhancement and contrast sensitivity. Real-life accounts of patients reveal that the program improves the patients’ functionalities, making daily operations much easier to accomplish through the use of this contemporary treatment model.